Unlike oral administered, which can cause stomach upset, intravenous offers a preferable option for minimizing discomfort without gastrointestinal side effects
The anastomosis and the ulcerative colitis at the same time were assessed grossly, biomechanically, clinically and microscopically ( Table 4 , Figs
Emibetuzumab (LY2875358) against c-Met and HGF and MP0250 against HGF and VEGF are two bispecific antibodies that prevent c-Met attachment to the ligand, increase the internalization, destroy c-Met molecules, and thereby reduce the signaling of the c-Met pathway [149, 174, 175]
the State Key Laboratory of Drug Research (SKLDR-2023-TT-04 to HEX)
GHK-Cu is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications